All relevant data are within the manuscript and its Supporting Information files.

Introduction {#sec006}
============

Increasing evidence suggests the presence of a long prodromal phase of Parkinson's Disease (PD), with nonmotor symptoms that may start decades before diagnosis \[[@pone.0224331.ref001]\]. One of those highly frequent prodromal symptoms is olfactory dysfunction. It typically occurs 4--8 years before diagnosis, although in some cases it can occur as early as 20 years before the first motor signs \[[@pone.0224331.ref002],[@pone.0224331.ref003]\]. Subjects with the combination of hyposmia and idiopathic REM Sleep Behavior Disorder (iRBD) are at high risk for conversion to PD or PD dementia of more than 60% over 5 years \[[@pone.0224331.ref004]\].

Olfactory dysfunction in neurodegeneration is not unique to PD but can be found also in Alzheimer's disease and Huntington's disease \[[@pone.0224331.ref005]\], yet patients with Multiple System Atrophy (MSA) or Progressive Supranuclear Palsy (PSP) seem to suffer less from olfactory loss \[[@pone.0224331.ref006],[@pone.0224331.ref007]\].

Neuropathological markers of PD could be linked with olfactory dysfunction, as Lewy-body pathology was found in the olfactory bulb, tract and anterior olfactory nucleus. Likewise alpha synuclein pathology was found in all five sub-regions of the primary olfactory cortex \[[@pone.0224331.ref008]\]. Dopaminergic treatment has no effect on odor identification performance in PD patients \[[@pone.0224331.ref009]\]. Together with PET studies that found no correlation between cerebral dopamine transporter activity and odor identification, these findings suggest that PD related olfactory loss most probably reflects a non-dopaminergic mechanism \[[@pone.0224331.ref010]\].

In order to screen for hyposmia there is a large variety of tests that examine an individual's ability to identify, detect, discriminate or remember odors \[[@pone.0224331.ref005]\] but often such tests differ in reliability, are not equated for non-olfactory task demands and use different odorants.

In addition, our biological infrastructure and our environment have a high impact to our odor identification abilities \[[@pone.0224331.ref011]\]. Even genetic variability within and between populations has to be taken into consideration \[[@pone.0224331.ref012],[@pone.0224331.ref013]\]. As a consequence, adaptation of olfactory tests to a given cultural setting is essential.

One of the most commonly used olfactory tests is the Sniffin' Sticks test-battery (Burghart Messtechnik, Wedel, Germany) that is available as a) the Sniffin' Sticks 12-identification test (SIT-12) and b) an olfactory test consisting of three different subtests with altogether 112 odorant sticks, testing threshold, discrimination and identification. Due to practical reasons the SIT-12 is the more widely used clinical olfactory test in everyday testing in otorhinolaryngological and neurological departments in Germany and other European countries \[[@pone.0224331.ref014]\]. It has been validated for clinical use in several European countries, i.e. in Great Britain, Germany, Turkey, Portugal and Denmark \[[@pone.0224331.ref014]--[@pone.0224331.ref018]\]. Several variants of the SIT test \[[@pone.0224331.ref019]\]\[[@pone.0224331.ref020]\]\[[@pone.0224331.ref021]\] and other odor identification tests \[[@pone.0224331.ref022]\] have been examined in an Asian population.

Yet this is the first study to investigate olfactory function in a North Chinese (Beijing) and German population of healthy subjects and PD patients by hands of a direct comparison of the SIT-12 test and a modified SIT-12 test both in a Chinese and German age matched cohort. The for China modified version of the SIT-12 test (Ch-SIT-12) takes into account cultural components by exchanging 4 odors as well as their according descriptors for any given odorant. The decision which odors were changed and which odors were chosen as replacement is based on the study by Shu et al. \[[@pone.0224331.ref021]\] Due to expert opinion, however, it was decided not to replace the odor shoeleather.

We hypothesized to find a significant difference in the distribution of incorrect answers in the Chinese cohort between the original SIT-12 and the adapted version and that not all odorants were correctly identified by \>75% in a normosmic northern Chinese population in the original version. Vice versa, we hypothesized that the adapted Chinese version of the SIT-12 test would result in falsely pathological results (lower than 75% correctly identified odors) in a healthy German cohort, consequently leading to false positive test results when used as a clinical marker for PD. For the patient groups we hypothesized that both the Chinese as well as the German PD patients would perform worse in the non-adapted version of the test in comparison to the adapted version.

Materials and methods {#sec007}
=====================

Participants {#sec008}
------------

The original SIT-12 test as well as the Ch-SIT-12 test were administered to 80 PD patients (41 German and 39 Chinese) and 170 healthy controls (100 German and 70 Chinese) who were subjectively normosmic and showed no known disease associated with olfactory dysfunction.

Subjects with rhinitis, history of sinunasal disease or known hyposmia out of other reasons than PD were excluded from this study. The study was approved by the Ethical Committees of the University of Ulm, Peking University First Hospital, and Beijing Hospital, and was performed in accordance with the ethical standards laid out by the Declaration of Helsinki. All prospectively examined patients and controls gave written informed consent. The PD diagnoses were made by board-certified neurologists specialized in movement disorders according to the new clinical Movement Disorder Society diagnostic criteria for PD \[[@pone.0224331.ref023]\].

Cohorts {#sec009}
-------

Additional to the primary analysis of the healthy probands (HP) we divided the cohort of healthy subjects in two groups for each country. One group of 32 Chinese and 42 German subjects that served as age-matched controls for patients, and a much younger group of 38 Chinese and 38 German subjects between 20 to 40 years of age in order to test if the different socio-environmental setting of these younger probands may have an influence to odor recognition in China and Germany. The patient group consisted of 39 Chinese and 41 German patients. For a summary of all demographic data for all groups and subgroups see [Table 1](#pone.0224331.t001){ref-type="table"}.

10.1371/journal.pone.0224331.t001

###### Demographic and clinical data for all Parkinson's Disease patients (all PD), the Chinese (Chinese PD) and German (German PD) cohorts of PD; healthy probands and its subgroups of young (20--40 years old) healthy subjects and age matched controls for the PD groups.

![](pone.0224331.t001){#pone.0224331.t001g}

                                                                all PD                  Chinese PD              German PD               all probands             Chinese probands         Chinese young probands   Chinese controls         German probands          German young probands   German controls
  ------------------------------------------------------------- ----------------------- ----------------------- ----------------------- ------------------------ ------------------------ ------------------------ ------------------------ ------------------------ ----------------------- -----------------------
  Number                                                        80                      39                      41                      170                      70                       38                       32                       100                      38                      42
  Gender (female/male)                                          32/48                   20/19                   12/29                   105/65                   43/27                    21/17                    22/10                    62/38                    23/15                   24/18
  Age years (mean ± SD; min/max)                                65.5 ± 9.3; 39.6/88.1   64.1 ± 9.2; 39.6/82.1   66.8 ± 9.2; 49.7/88.1   45.8 ± 16.7; 21.6/84.7   43.7 ± 17.4; 21.8/84.7   29.5 ± 5.1; 21.8/39.5    60.6 ± 10.1; 41.9/84.7   47.2 ± 16.2; 21.6/82.7   29.9 ± 5.5; 21.7/40.4   62.9 ± 8.6; 52.9/82.7
  Education (median (interquartile range))                      12.0 (6.0)              12.0 (7.0)              12.0 (3.38)             15.0 (5.0)               16.0 (7.0)               18.0 (4.0)               12.0 (6.0)               15 (13;17)               15.0 (3.5)              14.0 (4.0)
  Smoking (x/all)                                               13/80                   5/39                    8/41                    30/170                   2/70                     1/38                     1/32                     28/100                   7/38                    14/42
  Pack years (median (interquartile range))                     0.0 (0.0)               0.0 (0.0)               0.0 (0.0)               0.0 (0.0)                0.0 (0.0)                0.0 (0.0)                0.0 (0.0)                0.0 (2.0)                0.0 (0.0)               0.0 (2.75)
  SIT-12 (median of correct answers (interquartile range))      6.0 (4.0)               7.0 (3.0)               5.0 (4.5)               11.0 (1.0)               10.0 (2.0)               10.0 (2.0)               9.0 (3.0)                11.0 (2.0)               11.0 (2.0)              11.0 (1.25)
  Ch-SIT 12 (median of correct answers (interquartile range))   6.5 (4.0)               7.0 (4.0)               6.0 (4.5)               11.0 (2.0)               11.0 (1.25)              11.0 (2.0)               10.0 (1.0)               11.0 (2.0)               11.0 (1.0)              11.0 (2.25)
  Disease Duration in months (median (interquartile range))     42.0 (108.0)            24.0 (38.0)             96.0 (143.0)                                                                                                                                                                 
  UPDRS III (median (interquartile range))                      25.0 (22.0)             22.0 (18.0)             27.0 (22.0)                                                                                                                                                                  

Demographic data and clinical scores {#sec010}
------------------------------------

In addition to olfactory testing, disease duration was recorded and the disease severity was examined by the Unified Parkinson's Disease Rating Scale Part III (UPDRS-III). UPDRS-III was performed under ongoing treatment in the On state. For patients and controls the following information was recorded: age, gender, cumulative years of education and smoking habits (pack years). For a summary of all clinical data see [Table 1](#pone.0224331.t001){ref-type="table"}.

Olfactory testing {#sec011}
-----------------

The original SIT-12 test consists of 12 pens, filled with those odorants as depicted in [Fig 1](#pone.0224331.g001){ref-type="fig"}. The test is executed as a multiple-choice test. According to the suggested procedure by Hummel et al \[[@pone.0224331.ref024]\] the odor sticks are successively placed about 2--3 cm in front of the nose of the subject for a period of about 3 seconds, then the subject choses an item from a specified list of four descriptors for each stick \[[@pone.0224331.ref024]\].

![Odors of all 16 Sniffin' Sticks (bold) and descriptors (changed descriptor for the Chinese version in oblique).\
Blue colored sticks are those that remained unchanged in SIT-12 and Ch-SIT-12. The other correspondingly colored sticks present the original sticks and its adapted version (sticks 13--16) for the Chinese SIT-12. Mean values (± standard error of the mean) of correct answer rates for every single Sniffin' Stick for all German (G, N = 100) and Chinese (Ch; N = 70) healthy subjects.](pone.0224331.g001){#pone.0224331.g001}

For the adapted Chinese version of the SIT-12 (Ch-SIT-12), 4 odorants (cinnamon, liquorice, coffee and cloves) were replaced with sesame oil, soy sauce, chocolate and garlic. Both patients (PD) and HP in China and Germany performed both versions of the test. The decision to change the above-mentioned odors was based on the familiarity ratings of odors as described by Shu et al \[[@pone.0224331.ref021]\] and the experience of the Chinese authors of this study. In order to avoid retest effects, the test was performed with all 16 different odors successively presented as one test. The subjects were not informed about the exact purpose of the modifications made to the original SIT-12 test in order to avoid clichés in odor recognition answers. The sequence of the sticks for the German cohort was the original SIT-12 test followed by the 4 new odorants for the Chinese version ([Fig 1](#pone.0224331.g001){ref-type="fig"}). For the Chinese cohort the regionalized Chinese odorants replaced the original sticks within the sequence. The sorted-out sticks were annexed. When used as descriptors in other odorants of the original SIT-12 test, the exchanged odors names were used as descriptors in the Chinese version instead. However, a double testing of original and changed descriptors in both groups was not performed. According to the original validation of the SIT-12, we aimed at a successful identification rate of \>75% in a normosmic population \[[@pone.0224331.ref014],[@pone.0224331.ref024]\].

Statistical analysis {#sec012}
--------------------

All data are displayed as median value and interquartile range in brackets. Due to the non-normal distribution of the data, non-parametric tests were used. The Chinese and German subjects as well as healthy controls and patients were compared using the Mann-Whitney-U-Test. The relationship of the variables age, education, smoking habits, disease severity and disease duration with Sniffin Sticks performance were investigated using the Spearman's correlation coefficient. Receiver Operating Characteristic Curves (ROC-curves) were calculated for the different odorant sets in both patient groups in comparison to age matched controls. Given the exploratory nature of the study, the results should not be interpreted as confirmatory. No adjustment for multiple tests was made. A p-value \\ 0.05 was considered statistically significant.

Results {#sec013}
=======

Demographic data {#sec014}
----------------

Healthy subjects as well as patients did not differ significantly according age or smoking habits. The German age matched controls showed a significantly longer education period in comparison to controls (p = 0.02), there was no such significant difference in Chinese patients and controls. There were more male than female patients but more female than male age matched controls; yet neither in patients nor in controls there was a significant difference in gender distribution between the Chinese and German cohorts. Also there was no significant difference in odor identification rates according to gender in all controls. Severity of motor symptoms (UPDRS III) did not differ significantly between both patient groups but disease duration did (p\<0.0001) with a longer mean disease duration in German patients. A minor fraction of Chinese and German patients and controls were smokers. However, there was no significant difference in odor identification performance between smokers and non-smokers in any of the patient- and control-groups studied. Demographic Data are summarized in [Table 1](#pone.0224331.t001){ref-type="table"}.

Odor identification: Healthy probands {#sec015}
-------------------------------------

### Distribution of identification errors for single Sniffin' Sticks {#sec016}

The rate of correct answers for each Sniffin' Stick (± standard error of the mean (SEM)) is depicted in [Fig 1](#pone.0224331.g001){ref-type="fig"}. For the original SIT-12 in the German control population all sticks were recognized by more than 75% except for Item 10 (test odor 'pineapple') which was recognized by 74% of controls.

For the Chinese group of healthy probands (cHP) sticks 2 (shoeleather, 47%), 3 (cinnamon, 67%), 6 (lemon, 72%) and 9 (cloves, 48%) of the original SIT-12 were recognized by less than 75% of probands. With the regionally adapted Chinese version and the change of odors for the sticks 3, 7, 8 and 9 only 2 sticks (2, 6) remained beneath 75% identification rate. Note that the remaining difference to 75% with sticks 2 and 6 was well within SEM borders.

### Comparison of German and Chinese healthy probands {#sec017}

The whole group of Chinese and German HP (n = 170) showed a median score of correct answers of 11.0 (1.0) for SIT-12 and 11.0 (2.0) Ch-SIT-12. The difference was statistically significant (p = 0.02).

For the Chinese HP the median difference between the correct identifications of the SIT-12 (10.0 (2.0)) and Ch-SIT-12 (11.0 (1.25) was highly significant (p\<0.0009). Instead the German HP showed a median of 11.0 (2.0) correct answers for SIT-12 and 11.0 (2.0) correct answers for Ch-SIT-12 (p = 0.8).

For the subgroups of Chinese and German young HP (yHP) the results of SIT-12 and Ch-SIT-12 showed the same pattern as for the HP groups. SIT-12 showed a median of 10.0 (2.0) correct answers for the Chinese yHP vs. 11.0 (2.0) for the German yHP. For Ch-ST-12 the median was 11.0 (2.0) for Chinese yHP vs 11.0 (3.0) for the German yHP. The differences in correct answers between the original and localized test were highly statistically significant for the Chinese yHP (p = 0.005) but not for the German yHP (p = 0.7).

In summary the Chinese HP and yHP showed significantly better performance in the adapted Ch-SIT-12 than in the SIT-12. Interestingly the German HP and yHP performed equally good in SIT-12 and Ch-SIT-12.

When comparing the performances of the intended test sets for each group of HP (SIT-12 for the German HP and Ch-SIT-12 for the Chinese HP) the difference in performance was much lower with no significant difference with a median of 11.0 (2.0) for German HP and 11.0 (1.25) for Chinese HP (p = 0.06).

The numbers of correct answers for each group are shown in [Table 1](#pone.0224331.t001){ref-type="table"} and are depicted in [Fig 2](#pone.0224331.g002){ref-type="fig"}.

![Numbers of correct odor identifications as median with interquantile range and single measures as dots for all tested cohorts and subgroups as well as both tested Sniffin' Stick sets (SIT-12 = original German version; Ch-SIT-12 = adapted Chinese version).\
Blue = all healthy subjects (HP); Orange = subgrop of young (20--40 years old) healthy subjects (yHP); Red = all patients (Pat), Green = age matched subgroup of healthy subjects as control group for patients (CTL).](pone.0224331.g002){#pone.0224331.g002}

Odor identification: Comparison of patients and controls {#sec018}
--------------------------------------------------------

### SIT-12 {#sec019}

For the German group there was a highly significant difference (p\<0.0001) in odor identification abilities between patients (5.0 (4.5)) and controls (11.0 (1.25)). The same was true for the Chinese group (p\<0.0001; patients: 7.0 (3.0); controls: 9.0 (3.0)). The Chinese patients performed better than the German patients, but German patients show a much longer disease duration than the Chinese with a median of 24.0 (38.0) vs. 96.0 (143.0) months in the German group.

### Ch-SIT-12 {#sec020}

The Ch-SIT-12 showed the same pattern of results as SIT-12 with significant differences between patients and controls for both the German (p\<0.001, patients: 6.0 (4.5); controls: 11.0 (2.25) and the Chinese cohorts (p\<0.001, patients 7.0 (4.0); controls: 10.0 (1.0)).

### Comparison of SIT-12 and Ch-SIT-12 {#sec021}

For both SIT-12 and Ch-SIT-12 Chinese PD performed better by approximately 1 item than German PD and both patient groups performed better by approximately 1 score in the Ch-SIT-12 in comparison to the SIT-12. Note again that the Chinese patient group has a significantly shorter mean disease duration than the German patient group.

When comparing the performance between the original SIT-12 and the Ch-SIT-12 the German controls as well as the German young healthy subjects performed nearly equally good.

For all patients and controls measurements the median scores and interquartile ranges are shown in [Table 1](#pone.0224331.t001){ref-type="table"}. The median scores as well as every single patient and control measure are depicted in [Fig 2](#pone.0224331.g002){ref-type="fig"}.

Sensitivity and specificity of SIT-12 and Ch-SIT-12 {#sec022}
---------------------------------------------------

With a cutoff of \< 7.5 for correct answers out of 12 sticks, the original SIT-12 test discrimi-nated between German PD and HC with a sensitivity of 75% and a specificity of 98%. The ROC curve showed an area under curve of 0.93. With the regionalized Ch-SIT-12 test the Chinese cohort of PD and HC showed a sensitivity of 59% and specificity of 97% with an area under curve of 0.85. Note that the cross-testing (regionalized Chinese SIT with German cohort and original SIT-12 with Chinese cohort) shows a higher sensitivity with lower specificity both for Germany and China. ROC-curves and according numbers are depicted in [Fig 3](#pone.0224331.g003){ref-type="fig"}.

![Receiver operating characteristics (ROC-curves) for a threshold value of \> 7.5 for the comparison of German patients and controls (left) and Chinese patients and controls (right) for the original SIT-12 (blue) and the Chinese adapted version Ch-SIT-12 (red).](pone.0224331.g003){#pone.0224331.g003}

Possible factors influencing odor identification {#sec023}
------------------------------------------------

Correlation analysis showed no significant relationship for younger age (r = -0.14, p = 0.08) but a significant relation to longer education (r = 0.16, p = 0.03) with a better performance over all 16 Sniffin' Sticks used in the group of 170 healthy probands. For the patient group of 80 PD there was no significant relation to age, education and disease duration but there was a significant relation with higher (worse) UPDRS III scores (r = -0.26, p = 0.03) and worse performance in the Sniffin Sticks.

Discussion {#sec024}
==========

Odor identification is a simple yet useful tool that helps to discriminate PD from other causes of parkinsonism \[[@pone.0224331.ref002]\]. However, smells are subject to cultural differences, so that test procedures have to be adapted to the regional circumstances and habits where they are intended for use \[[@pone.0224331.ref025]\]. In this study we investigated a regionalized set of odors for the SIT-12 test for a Chinese population. We found that the modified Ch-SIT-12 showed the best specificity but fairly low sensitivity to discriminate the Chinese PD patients from the age matched controls cohort. The original German SIT-12 test proved to be the best test-constellation to discriminate the German cohort of patients and controls and showed a high sensitivity at the cost of a low specificity in the Chinese cohort.

Krismer et al. \[[@pone.0224331.ref026]\] found that the identification test had a similar area under curve compared with the sum score of the whole Sniffin' Sticks test battery, moreover the identification test was superior to any of the other subtests that are threshold and discrimination. In this study we examined one of the most commonly used European odor screening identification tests, the SIT-12 for its application in Germany and a northern Chinese (Beijing) environment in the original German version and in a regionally adapted Chinese version (Ch-SIT-12). The special feature of this study was that the close cooperation of the working groups in Beijing and Ulm made it possible to conduct and compare the examinations at the same time on adapted German and Chinese collectives.

It is of note that the Chinese and German patient cohorts showed a significantly different disease duration with a much shorter median duration for the Chinese patients. However, Nielsen et al \[[@pone.0224331.ref027]\] comment, that the majority of studies that investigated olfactory dysfunction as a possible progression marker did not find disease duration to be a significant independent predictor of the olfactory score.

In comparison to one of the most recent studies of the unmodified SIT-12 test in China by Huang et al. \[[@pone.0224331.ref028]\] we could not replicate the high specificity of 81.5% but we elicited the same tendency to a relatively lower specificity and a high sensitivity at the commonly used cut off value of \> 7.5 correct answers. The same tendency can be seen in SIT-12 testing in Spain where López Hernández et al showed 70% sensitivity and 83% specificity \[[@pone.0224331.ref029]\].

As depicted in the review of olfactory testing procedures in PD by Nielsen et al. \[[@pone.0224331.ref027]\] the sensitivity and specificity values vary considerably. Also Krismer et al \[[@pone.0224331.ref026]\] could show that manipulating the threshold for cut-off values for the identification test resulted in either excellent sensitivity or high specificity in discriminating PD patients from HC. Krismer et al \[[@pone.0224331.ref026]\] point out that values of high specificity are useful to confirm a diagnosis. Regardsing this, it is noteworthy that both in German and Chinese probands the respective "non-regionalized" versions of the SIT-12 the ROCs showed a different pattern with high sensitivity scores at the expense of specificity. This is a non-favorable characteristic for a test that is intended to be used as a differential-diagnostic tool for a neurodegenerative disease.

The SIT-12 test demands \>75% correct answers for each odorant in a normosmic population \[[@pone.0224331.ref014],[@pone.0224331.ref024]\]. Except for Stick 10 (pineapple) with 74% mean correct answers this was accomplished for the German HPs. For the Chinese cohort of HPs, Sniffin' Stick 2 (shoeleather) showed an unexpectedly low recognition rate, especially since an exchange of this stick against a regionalized version was not provided. For those odors for which an exchange was anticipated and implemented in Ch-SIT-12, a mixed picture emerges. Cloves that showed a low recognition rate of under 50% in den Chinese HP was replaced by garlic with a now high rate of 97%. Yet liquorice and coffee that were replaced by soy sauce and chocolate odors were already recognized in the original version so well that an exchange would not have been necessary. To sum up the single Sniffin' Stick characteristics, the adapted Ch-SIT-12 test worked as intended with correct answer rates close to (within SEM borders) or well above 75%, except for stick 2.

Most interestingly the German cohort of healthy subjects performed excellent also in the Ch-SIT-12 test with no statistical difference to the original test ([Fig 2](#pone.0224331.g002){ref-type="fig"}). However, the Chinese healthy probands showed a significantly worse performance in the original SIT-12 in comparison to Ch-SIT-12. By contrast, the German HPs showed a very good detection rate also for all of the Chinese replacement odors. The reasons can only be speculated, but it is well known that perception relies on previously acquired knowledge \[[@pone.0224331.ref030]\]. Therefore, it seems plausible, that the great popularity and widespread availability of Chinese food in Germany could be a major factor. Related to this was the assumption that young adults may do even better than older people. However, this could not be confirmed in the investigation. Although the known age-related worsening of the olfactory function \[[@pone.0224331.ref017]\] was found to be significant both in the Chinese and German HPs, there was no significant difference between the characteristic Chinese and German odors in the older controls in comparison to the younger ones.

The study has several shortcomings that need to be addressed. An ENT examination was not carried out in order to exclude other diseases with olfactory dysfunction. Yet it was asked for known diseases and for subjective normal smelling ability before inclusion of the probands. In addition, the study design with the coupled examination of the SIT-12 and Ch-SIT-12 test-sets is unusual. However, only through this procedure it was possible to avoid a re-test effect of the 8 unchanged odors within one subject.

In summary, we found that the modified SIT-12 test offers a quick way to screen for hyposmia in PD patients in a Chinese population. In retrospective the exchange of the odors liquorice and coffee would not have been necessary, as these odors showed equally high recognition rates in Chinese and German probands. However, also the replacement odors performed well. According to the one remaining odor (shoeleather) that performed much lower than the demanded 75% recognition rate, it will be necessary to investigate in a subsequent study if the adaption of this odor will be able to further improve test performance.

Supporting information {#sec025}
======================

###### Minimal data set.

Complete data set for Sniffin' Sticks results, demographic data and clinical scores for Chinese and German patients, controls and healthy probands.

(XLSX)

###### 

Click here for additional data file.
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Reviewer \#1: Yes

Reviewer \#2: Partly

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: No

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: Review

PLPS one manuscrpit PONE D 19 15889

By inkhardt E et al.

This manuscript reports the first study to directly compare olfactory function in a North Chinese and a German cohort of healthy subjects and Parkinson patients. For testing olfactory function the SIT12 (Sniffin Sticks) test and a modified CH-SIT12 test -- the later adapted to the Chinese culture -- are employed.

The study is explanatory and therefore does not fulfill the strict criteria of a test-retest development with all the statistical ramifications. By testing all 16 odors in one test procdur, the need for adjusting the analysis for multiple testing was avoided.

There are a few comments:

Line 86 is not clear -- cited: for the patient groups we likewise hypothesize ...... please change

Line 119: was the UPDR III rating performed in On or Off -- I assume the PD patients were under treatment.

Line 167: Is there evidence that olfactory function deteriorates during the progression of PD or is the hyposmia stable over time ?

Please quote respective references.

Table 1

20 % of German PD patients were smokers. Did they perform differently ?

Were the Chinese PD patients de novo patients ? They had a disease duration of about 3 years.

Was the Sniffin Test performed by asking the person to sniff once or twice ? -- there is a difference in the results if you sniff once or twice

Line 191-199: For a naive reader this paragraph is slightly confusing. Please try to present the data in a simpler way.

Discussion:

Line 312: The most likely explanation of the results is the fact that German subjets are widely exposed to Chinese Cuisine.

It is not surprising that liquorice and coffee are well recognized by the Chinese Healthy controls and PD patients. This is part of their day to day diet . Thus it is not clear why these two odors where exchanged. This should be explained in the methods.

Conclusion: it may be changed. As in the strict sense the CH-SIT12 would only need an exchange of 2 odors and a replacement for the oder shoeleather.

Criteria for publications:

Original

Trans-national

Nicely carried out

Minor modifications requested.

Reviewer \#2: The authors present an interesting study on the cross-cultural adapted olfactory screening test (Sniffin' Sticks 12-identification test) for the differentiation between Parkinson's disease and healthy subject. The purpose of the work is meaningful as we indeed sense the impact of cultural difference on the accuracy of olfactory screening tests in clinical practice. Yet, I have the following concerns that need to be addressed.

1\. The statistics are incorrect. The student t test can be used in data with normal distribution. The author did not indicate the feature of the data. Judging from table 1, non-normal distribution is very likely for disease duration, smoking years, UPDRS III scores in this cohort. If that's the case, the data should be firstly displayed as median value and interquartile range, then analyzed using Kruskal-Wallis test. Likewise, Pearson correlation is used in normally distributed data as well. The authors need to indicate the distribution of the data, and rectify the analytic approach and the result accordingly.

2\. The conclusion that the adapted Chinese version screening test (Ch-SIT-12) is more useful than the original SIT-12 can't be reached according to the result. The ROC curve shows that the non-adapted version has higher AUC than the adapted version. Besides, as the disease duration and gender differ between Chinese and German patients, the superiority may not be suitable to analyze in the first place.

3\. Can the authors indicate who conducted the olfactory test for the subjects? Is it the same group performing the olfactory test for these subjects? Have they been trained in the same way? Is there a common protocol for both German and Chinese practitioners? Is there any blindness used? Is there inter-rater variability tested? I'm concerned as Chinese subjects performed better on both the non-adapted (SIT-12) and the adapted olfactory test (ch-SIT-12). Besides, the curve in ROC figure is smoother in German subjects while a small bump can be seen in the Chinese subjects, indicating larger variability in Chinese subject. According to Table 1, larger SD is shown. Can the variability come from different raters?

4\. Have the abstract finished? There is an unfinished sentence in the result parts. There are grammar errors in the abstract. And the expression used in the abstract need to be more simplified and concise.

5\. I suggest a brief summary of the main finding and implication of this study in the first paragraph in the discussion part.

6\. Several grammar errors are present across the article. And th

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Revised manuscript PONE-D-19-15889: Olfactory Screening of Parkinson's Disease patients and healthy subjects in China and Germany: A study of cross-cultural adaptation of the Sniffin' Sticks 12-identification test

In the following, we reply to the reviewers' comments on a point-to-point basis.

Reviewer \#1:

This manuscript reports the first study to directly compare olfactory function in a North Chinese and a German cohort of healthy subjects and Parkinson patients. For testing olfactory function the SIT12 (Sniffin Sticks) test and a modified CH-SIT12 test -- the later adapted to the Chinese culture -- are employed.

The study is explanatory and therefore does not fulfill the strict criteria of a test-retest development with all the statistical ramifications. By testing all 16 odors in one test procdur, the need for adjusting the analysis for multiple testing was avoided.

There are a few comments:

Line 86 is not clear -- cited: for the patient groups we likewise hypothesize ...... please change

The sentence was changed to: For the patient groups we hypothesized that both the Chinese as well as the German PD patients would perform worse in the non-adapted version of the test in comparison to the adapted version.

Line 119: was the UPDR III rating performed in On or Off -- I assume the PD patients were under treatment.

The reviewer's assumption is correct; the patients were rated in the On state. The following sentence was added to the manuscript: UPDRS-III was performed under ongoing treatment in the On state.

Line 167: Is there evidence that olfactory function deteriorates during the progression of PD or is the hyposmia stable over time ?

Please quote respective references.

The reviewer point to an important question as we found a significant difference in disease duration between the Chinese and the German patient group. However, the corresponding literature on this topic does not show a clear picture. Also in our patient cohorts we did not find a significant correlation between disease duration and sniffin' sticks performance.

To address the topic, the following paragraph was added to the discussion section of the manuscript: It is of note that the Chinese and German patient cohorts showed a significantly different disease duration with a much shorter median duration for the Chinese patients. However, Nielsen et al (Nielsen et al., 2018) comment, that the majority of studies that investigated olfactory dysfunction as a possible progression marker did not find disease duration to be a significant independent predictor of the olfactory score.

Table 1

20 % of German PD patients were smokers. Did they perform differently?

There was no statistically significant difference in odor identification performance between smokers and non-smokers in any of the cohorts studied (German patients and controls, Chinese patients and controls). The corresponding results were added to the results section of the manuscript reading: "...A minor fraction of Chinese and German patients and controls were smokers. However, there was no significant difference in odor identification performance between smokers and non-smokers in any of the patient- and control-groups studied."

Were the Chinese PD patients de novo patients ? They had a disease duration of about 3 years.

The Chinese patients were not de novo patients.

Was the Sniffin Test performed by asking the person to sniff once or twice ? -- there is a difference in the results if you sniff once or twice.

According to the suggested procedure by Hummel et al (Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G. "Sniffin" sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 1997 Feb 1;22(1):39--52) for odor presentation the cap was removed by the experimenter for \~3 s and the pen\'s tip was placed \~2 cm in front of both nostrils.

The corresponding sentence in the methods section has been changed as follows: . "... According to the suggested procedure by Hummel et al (Hummel et al., 1997) the odor sticks are successively placed about 2-3 cm in front of the nose of the subject for a period of about 3 seconds.

Line 191-199: For a naive reader this paragraph is slightly confusing. Please try to present the data in a simpler way.

The paragraph was rewritten and reads now: For the subgroups of Chinese and German young HP (yHP) the results of SIT-12 and Ch-SIT-12 showed the same pattern as for the HP groups. SIT-12 showed a median of 10.0 (2.0) correct answers for the Chinese yHP vs. 11.0 (2.0) for the German yHP . For Ch-ST-12 the median was 11.0 (2.0) for Chinese yHP vs 11.0 (3.0) for the German yHP. The differences in correct answers between the original and localized test were highly statistically significant for the Chinese yHP (p=0.005) but not for the German yHP (p=0.7).

In summary the Chinese HP and yHP showed significantly better performance in the adapted Ch-SIT-12 than in the SIT-12. Interestingly the German HP and yHP performed equally good in SIT-12 and Ch-SIT-12.

Discussion:

Line 312: The most likely explanation of the results is the fact that German subjets are widely exposed to Chinese Cuisine.

It is not surprising that liquorice and coffee are well recognized by the Chinese Healthy controls and PD patients. This is part of their day to day diet . Thus it is not clear why these two odors where exchanged. This should be explained in the methods.

The decision to change the above-mentioned odors was based on the familiarity ratings of odors as described by Shu et al (Shu C-H, Yuan B-C. Assessment of odor identification function in Asia using a modified "Sniffin' Stick" odor identification test. Eur Arch Oto-Rhino-Laryngology. 2007 Dec 7;265(7):787--90) and the experience of the Chinese authors of this study.

This paragraph has been added to the methods part of the manuscript.

Conclusion: it may be changed. As in the strict sense the CH-SIT12 would only need an exchange of 2 odors and a replacement for the odor shoeleather.

According to the reviewer's suggestion the conclusion has been rewritten and reads now: "...In summary, we found that the modified SIT-12 test offers a quick way to screen for hyposmia in PD patients in a Chinese population. In retrospective the exchange of the odors liquorice and coffee would not have been necessary, as these odors showed equally high recognition rates in Chinese and German probands. However, also the replacement odors performed well. According to the one remaining odor (shoeleather) that performed much lower than the demanded 75% recognition rate, it will be necessary to investigate in a subsequent study if the adaption of this odor will be able to further improve test performance."

Reviewer \#2:

The authors present an interesting study on the cross-cultural adapted olfactory screening test (Sniffin' Sticks 12-identification test) for the differentiation between Parkinson's disease and healthy subject. The purpose of the work is meaningful as we indeed sense the impact of cultural difference on the accuracy of olfactory screening tests in clinical practice. Yet, I have the following concerns that need to be addressed.

1\. The statistics are incorrect. The student t test can be used in data with normal distribution. The author did not indicate the feature of the data. Judging from table 1, non-normal distribution is very likely for disease duration, smoking years, UPDRS III scores in this cohort. If that's the case, the data should be firstly displayed as median value and interquartile range, then analyzed using Kruskal-Wallis test. Likewise, Pearson correlation is used in normally distributed data as well. The authors need to indicate the distribution of the data, and rectify the analytic approach and the result accordingly.

According to the reviewer's suggestion the statistics have been newly calculated. Now all data in the text and the table (except for age) are displayed as median and interquantile rage. Due to the non-normal distribution of the data, non-parametric tests were used. The Chinese and German subjects as well as healthy controls and patients were compared using the Mann-Whitney-U-Test. The relationship of the variables age, education, smoking habits, disease severity and disease duration with sniffin sticks performance were investigated using the Spearman's correlation coefficient.

2\. The conclusion that the adapted Chinese version screening test (Ch-SIT-12) is more useful than the original SIT-12 can't be reached according to the result. The ROC curve shows that the non-adapted version has higher AUC than the adapted version. Besides, as the disease duration and gender differ between Chinese and German patients, the superiority may not be suitable to analyze in the first place.

According to the reviewer's suggestion the conclusion has been rewritten and reads now as follows: "...In summary, we found that the modified SIT-12 test offers a quick way to screen for hyposmia in PD patients in a Chinese population. In retrospective the exchange of the odors liquorice and coffee would not have been necessary, as these odors showed equally high recognition rates in Chinese and German probands. However, also the replacement odors performed well. According to the one remaining odor (shoeleather) that performed much lower than the demanded 75% recognition rate, it will be necessary to investigate in a subsequent study if the adaption of this odor will be able to further improve test performance."

3\. Can the authors indicate who conducted the olfactory test for the subjects? Is it the same group performing the olfactory test for these subjects? Have they been trained in the same way? Is there a common protocol for both German and Chinese practitioners? Is there any blindness used? Is there inter-rater variability tested? I'm concerned as Chinese subjects performed better on both the non-adapted (SIT-12) and the adapted olfactory test (ch-SIT-12). Besides, the curve in ROC figure is smoother in German subjects while a small bump can be seen in the Chinese subjects, indicating larger variability in Chinese subject. According to Table 1, larger SD is shown. Can the variability come from different raters?

All raters have been trained in the same way. There was a detailed and common protocol for othe German and Chinese practitioners. The test procedure was the one, described by Hummels et al (Hummel T, et al. "Sniffin" sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses. 1997 Feb 1;22(1):39--52.) which is the standard procedure for the test.

Due to the nature of the test procedure and the task of the raters there is no need for a blinded rater and/or inter-rater variability. All raters strictly followed the standardized procedures i.e. presenting the sticks to both nostrils for 3 seconds each in a distance of 2-3 centimeters and document the answer of the proband

.

4\. Have the abstract finished? There is an unfinished sentence in the result parts. There are grammar errors in the abstract. And the expression used in the abstract need to be more simplified and concise.

The unfinished sentence has been removed. The abstract has been revised according to the reviewer's suggestion

5\. I suggest a brief summary of the main finding and implication of this study in the first paragraph in the discussion part.

Following the reviewer's suggestions the first paragraph was rewritten and reads now: "Odor identification is a simple yet useful tool that helps to discriminate PD from other causes of parkinsonism (2). However, smells are subject to cultural differences, so that test procedures have to be adapted to the regional circumstances and habits where they are intended for use (25). In this study we investigated a regionalized set of odors for the SIT-12 test for a Chinese population. We found that the modified Ch-SIT-12 showed the best specificity but fairly low sensitivity to discriminate the Chinese PD patients from the age matched controls cohort. The original German SIT-12 test proved to be the best test-constellation to discriminate the German cohort of patients and controls and showed a high sensitivity at the cost of a low specificity in the Chinese cohort."

6\. Several grammar errors are present across the article.

The article has been carefully revised for grammar errors.
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PONE-D-19-15889R1

Dear Dr. Pinkhardt,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at <https://www.editorialmanager.com/pone/>, click the \"Update My Information\" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

With kind regards,

Jing A. Zhang, MD, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: (No Response)

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: No comments.
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7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).
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Dear Dr. Pinkhardt:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

For any other questions or concerns, please email <plosone@plos.org>.
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PLOS ONE Editorial Office Staff

on behalf of

Dr. Jing A. Zhang

Academic Editor

PLOS ONE

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.
